glp-1 lean mass loss agonists and changes in body and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis The Muscle Loss Conversation No

These changes are often due to the hormonal shifts caused by the medications

More practical contributors to heart rate increases, especially early in therapy, may include volume depletion from gastrointestinal side effects such as nausea, vomiting, and diarrhea, which are common during GLP-1 receptor agonist initiation

cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV

(3) Metformin may also boost GLP-1 release in the gut by hindering bile acid reabsorption and raising bile acid levels, indirectly triggering GLP-1 secretion from L cells